Study guide
11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
Certified Nutrition Support Clinician CNSC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Nutrition Screening, Dietary Evaluation & Energy Requirements
1.1 Nutrition Screening & Validated Risk Tools 1.2 Dietary History & Nutrient Intake Assessment 1.3 Energy Expenditure Estimation & Indirect Calorimetry
2 Chapter 2: Macronutrients, Micronutrients & Fluid Management
2.1 Protein Requirements & Nitrogen Balance 2.2 Fluid Requirements & Electrolyte Homeostasis 2.3 Essential Vitamins & Trace Elements
3 Chapter 3: Anthropometrics, Physical Exam & Malnutrition Consensus
3.1 Anthropometric Assessment & Body Composition 3.2 Nutrition-Focused Physical Examination (NFPE) 3.3 AND/ASPEN & GLIM Malnutrition Criteria
4 Chapter 4: Pediatric & Specialized Nutrition Assessment
4.1 Pediatric & Neonatal Nutrition Assessment 4.2 Biochemical Assessment, Visceral Proteins & Inflammation
5 Chapter 5: Enteral Nutrition Access & Tube Management
5.1 Enteral Access Modalities & Route Selection 5.2 Tube Placement Verification & Stoma Site Care
6 Chapter 6: Enteral Formulation, Regimen Design & Administration
6.1 Enteral Formula Classification & Selection 6.2 Enteral Delivery Methods & Infusion Schedules 6.3 Enteral Fluid Management & Free Water Requirements
7 Chapter 7: Enteral Complications & Medication Administration
7.1 Enteral Gastrointestinal Complications 7.2 Enteral Metabolic, Mechanical & Pulmonary Complications 7.3 Drug-Nutrient Interactions & Enteral Medication Delivery
8 Chapter 8: Parenteral Nutrition Indications, Access & Formulation Design
8.1 Parenteral Nutrition Indications & Venous Access Routes 8.2 Peripheral Parenteral Nutrition (PPN) Parameters 8.3 Central PN Macronutrient Formulation
9 Chapter 9: Parenteral Additives, Compounding & Physical Stability
9.1 Parenteral Electrolytes, Trace Elements & Vitamins 9.2 Calcium-Phosphate Solubility & Precipitation Risks 9.3 Physical Stability, Total Nutrient Admixtures & Filtration
10 Chapter 10: Parenteral Complications, CLABSI & Organ Toxicities
10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks 10.2 Refeeding Syndrome Pathophysiology & Prevention 10.3 Parenteral Nutrition-Associated Liver Disease & Metabolic Bone Disease
11 Chapter 11: Critical Care, Obesity & Pulmonary Nutrition Support
11.1 Critical Illness, Sepsis & Trauma Nutrition 11.2 Nutrition Support in Obesity & Hypocaloric Feeding 11.3 Pulmonary Failure & Mechanical Ventilation 11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
12 Chapter 12: Organ Failure: Renal, Hepatic & Gastrointestinal Support
12.1 Acute Kidney Injury & Renal Replacement Therapy 12.2 Cirrhosis, Hepatic Encephalopathy & Acute Pancreatitis 12.3 Short Bowel Syndrome & Intestinal Failure
13 Chapter 13: Oncology, Surgical Care & Intestinal Failure
13.1 Oncology Nutrition & Cancer Cachexia 13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS) 13.3 Enterocutaneous Fistulas & Severe Malabsorption
14 Chapter 14: Process Management, Compounding Safety & Home Nutrition Support
14.1 PN Order Verification, Compounding Safety & USP Standards 14.2 Home Nutrition Support (HNS) & Care Transitions 14.3 Nutrition Support Policies, Product Shortages & Patient Education
15 Chapter 15: Professional Practice, Ethics & Interdisciplinary Care
15.1 Ethical Principles & Withholding/Withdrawing Artificial Nutrition 15.2 The Interdisciplinary Nutrition Support Team 15.3 Quality Improvement, Malnutrition Documentation & Clinical Standards 15.4 Critical Appraisal of Nutrition Research & Evidence
11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
Key Takeaways Explain This Topic AI
Translate each nutrition diagnosis into measurable short-term safety/delivery goals and longer-term outcome or transition goals, each with a time frame and reassessment trigger.
Monitor what was actually delivered—not merely ordered—and integrate access function, tolerance, fluid balance, laboratory data, anthropometrics, functional status, and adherence.
When goals are missed, verify delivery and data quality first, identify the limiting cause, modify the smallest relevant part of the regimen, and specify when the response will be checked.
Reevaluate adjunctive medications by indication, measurable benefit, adverse effects, interactions, renal/hepatic dosing, and explicit continuation or stop criteria.
Transition or discontinue nutrition support when the alternative route reliably meets needs and the plan includes overlap, education, monitoring ownership, and relapse criteria.
Last updated: October 2026
11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
Clinical Core: The care plan is a closed clinical loop: assess, identify the nutrition problem and cause, prescribe a measurable intervention, monitor actual response, and revise the plan. A technically correct formula is not adequate if it lacks goals, delivery verification, ownership, and a reassessment date.
From Assessment to a Testable Plan
Begin with a concise problem statement supported by baseline evidence. Separate the problem from its cause and manifestations. For example: inadequate energy delivery related to repeated procedure holds, evidenced by an average delivered volume of 52% of the prescription over 3 days and continued weight loss. That statement points toward interruption management; simply increasing the ordered rate without examining holds may worsen risk without fixing delivery.
A complete plan records:
The indication for EN, PN, or combined therapy and why a safer route is insufficient.
Energy, protein, fluid, and micronutrient targets, including the weight and method used.
Formula or PN composition, route, access, dose, rate, schedule, and advancement plan.
Short- and long-term goals with time frames.
Monitoring measures, frequency, responsible clinician, and action thresholds.
Education needs, preference, affordability, caregiver capacity, and anticipated disposition.
Criteria to modify, hold, transition, or stop therapy.
Short-Term and Long-Term Goals
Goals should be specific, measurable, achievable, relevant, and time-bound. “Improve nutrition” is not measurable.
Goal horizon Typical focus Example
Hours to 3 days Safety, access, initiation, delivery, metabolic tolerance Phosphorus, potassium, and magnesium remain maintainable while calories advance by one-third of goal every 1–2 days
Several days to 2 weeks Adequacy, tolerance, wound or functional trajectory Deliver at least 80% of the individualized protein target over the next 72 hours without recurrent vomiting
Weeks to months Growth, weight or body-composition trend, function, healing, independence Caregiver independently performs HPN connection and emergency procedures before discharge
Transition endpoint Alternative route and discontinuation Oral/enteral intake consistently provides the agreed threshold for several days with stable hydration and weight trend
The time horizon matters. A short-term goal may prioritize safe delivery rather than weight gain. A long-term goal should connect therapy to an outcome meaningful to the patient, such as strength, wound healing, growth, ability to complete treatment, or home independence.
- Monitoring Domains
- Delivery and Adherence
Calculate actual delivery:
Delivery adequacy (%) = volume or nutrient actually received prescribed amount × 100 \text{Delivery adequacy (\%)} = \frac{\text{volume or nutrient actually received}}{\text{prescribed amount}} \times 100 Delivery adequacy (%) = prescribed amount volume or nutrient actually received × 100
Review procedure holds, pump history, discarded formula, missed PN time, medication conflicts, access problems, oral intake, and caregiver barriers. A patient can fail a goal because the prescription was not delivered, because it was physiologically intolerable, or because the original estimate was wrong; these require different actions.
Clinical and Access Response
For EN, examine tube position or stoma, patency, aspiration risk, stool and emesis pattern, abdominal findings, hydration, and medication causes of symptoms. For PN, examine the vascular access device, infection or thrombosis signs, infusion accuracy, glucose pattern, fluid status, and compounding or administration problems.
Laboratory and Functional Response
Choose tests that can change management. Electrolytes, glucose, renal function, liver tests, triglycerides, blood count, and selected micronutrients are ordered according to route, stability, disease, and duration. Interpret trends with inflammation, fluid shifts, medications, organ function, and assay limitations. Pair biochemical data with weight trajectory, physical findings, strength or function, wound progress, and patient-reported tolerance.
A Structured Reassessment Sequence
When a target is missed or toxicity appears:
Confirm the data. Verify weight conditions, sampling time, pump records, and intake/output accuracy.
Confirm access and delivery. Was the prescription received through a functioning route?
Compare with the goal and time frame. Identify the magnitude and clinical importance of the gap.
Identify the dominant cause. Consider disease progression, fluid change, intolerance, adherence, medication, incorrect requirements, or a transition in goals of care.
Modify the relevant component. Adjust rate, volume, composition, route, schedule, fluid, electrolytes, or the goal itself.
Define the next check. Record what response is expected, by when, who reviews it, and the threshold for escalation.
Avoid changing several variables at once unless the patient is unstable. A controlled change makes the response interpretable.
Adjunctive Pharmacotherapy
Medications may support—but do not replace—a corrected nutrition plan. Examples include prokinetics for documented gastric dysmotility, pancreatic enzymes for exocrine insufficiency, insulin for PN-associated hyperglycemia, antidiarrheal or antisecretory agents in high-output states, bile-acid binders for selected bile-acid diarrhea, and micronutrient repletion for confirmed or likely deficits.
At each reassessment ask: Is the original indication still present? Is there an objective benefit? Is the dose appropriate for renal and hepatic function? Does the drug interact with the formula or feeding schedule? Are adverse effects creating a new nutrition problem? What is the stop or de-escalation criterion? For example, a prokinetic continued without benefit can cause harm; insulin requirements may fall abruptly when cyclic PN stops.
Transition and Discontinuation
Transition is a monitored process, not a single order. Verify that the receiving route is safe and consistently meets the agreed energy, protein, fluid, and medication needs. Account for absorption, not just intake. Reduce the supplemental route in steps when appropriate, monitor hydration and glucose, and avoid gaps caused by supplier or setting changes.
Patient and caregiver education uses teach-back and demonstration. The learner should explain the purpose of therapy, identify warning signs, perform required skills, and know whom to contact. Document the final prescription, monitoring schedule, pending results, responsible clinician, supply plan, and criteria to restart or escalate support.